Starting
Initialising…
0%
BRCA1
Final classification
Pathogenic
BRCA1 c.135-1G>T · p.?
BRCA1

The BRCA1 c.135-1G>T (NP_009225.1:p.?) variant has been observed in somatic cancers in COSMIC and has been reported in ClinVar with a pathogenic expert-panel classification.

Gene
BRCA1
Transcript
NM_007294.4
HGVS · transcript:coding
NM_007294.4:c.135-1G>T
Consequence
N/A
GRCh38
chr17:43106534 C>A
GRCh37
chr17:41258551 C>A
Basis ENIGMA BRCA1 and BRCA2 Specification v1.2 final-classification framework (Table 3 criteria-combination rules from final_classification_framework).
ENIGMA BRCA1 and BRCA2 Specification v1.2 final-classification framework (Table 3 criteria-combination rules from final_classification_framework).
Classification rationale
PVS1PP4PP5 Pathogenic
BRCA1 c.135-1G>T

The BRCA1 c.135-1G>T (NP_009225.1:p.?) variant has been observed in somatic cancers in COSMIC and has been reported in ClinVar with a pathogenic expert-panel classification.1 This variant is present at very low frequency in population databases, with gnomAD v2.1 AF 7.14e-06 (2/280296 alleles) and gnomAD v4.1 AF 4.42e-06 (7/1583254 alleles), which is below benign frequency thresholds but does not meet the ENIGMA PM2 requirement for absence from controls.2 RNA and multifactorial evidence support a damaging splice effect for this variant, including exon 5 deletion in splicing studies, ENIGMA assignment of PVS1 (RNA), a reference-set posterior probability of 0.99999838416, and a BRCA1 clinical-history likelihood ratio of 59.69 across 7 probands, supporting PP4_Strong.3 In silico splicing analysis predicts a strong splice effect, with a SpliceAI maximum delta score of 0.86, which is consistent with disruption of normal splicing but is not counted separately as PP3 because the same splice evidence is already captured under the PVS1 framework.4

PVS1 + PP4 + PP5 Pathogenic
3 vcep_specifications_table4_v1_2_2024_11_18vcep_supplementarytables_v1_2_2024_11_18vcep_humu_40_1557_s001vcep_pmid_31853058_brca1_clinical_history_lrPMID:20020529 ↗PMID:31853058 ↗
4 spliceai ↗pvs1_variant_assessmentcspec ↗
Gene diagram · NM_007294.4 · variants mapped to exon structure
BRCA1 NM_007294.4
Fetching transcript structure from UCSC…
Applied criteria · 3 met · select any tile
Met
Not met
Not assessed
N/A
Strength very strong supporting
Pathogenic evidence
PVS
PS
PM
PP
Benign evidence
BA
BS
BP
Rationale
Select a criterion.
Sources
Evidence used
    Gaps remaining
      Rule
      Research & evidence
      Population frequency · supports pathogenic
      gnomAD v4.1 screenshot
      gnomAD v4.1
      gnomAD v2.1 screenshot
      gnomAD v2.1
      v4.1
      This variant is present in gnomAD v4.1 (AF= 4.42127e-06; MAF= 0.00044%, 7/1583254 alleles, homozygotes = 0) and has highest observed frequency in the European (non-Finnish) population (AF= 6.06741e-06; MAF= 0.00061%, 7/1153704 alleles, homozygotes = 0); grpmax FAF= 2.52e-06.
      v2.1
      This variant is present in gnomAD v2.1 (AF= 7.13531e-06; MAF= 0.00071%, 2/280296 alleles, homozygotes = 0) and has highest observed frequency in the European (non-Finnish) population (AF= 1.56177e-05; MAF= 0.00156%, 2/128060 alleles, homozygotes = 0).
      Allele frequency by ancestry
      three datasets · side by side
      gnomAD v4.1
      0.00044% · 7 / 1,583,254
      0 hom · FAF 0.00025%
      European (non-Finnish)
      7 / 1,153,704
      0.00061%
      + 9 not observed (Remaining individuals, Admixed American, European (Finnish), Amish, East Asian, Middle Eastern, South Asian, Ashkenazi Jewish, African/African American)
      gnomAD v2.1
      0.00071% · 2 / 280,296
      0 hom
      European (non-Finnish)
      2 / 128,060
      0.0016%
      + 7 not observed (African/African American, Admixed American, Ashkenazi Jewish, East Asian, European (Finnish), Remaining individuals, South Asian)
      ClinVar screenshot
      ClinVar
      This variant has been reported in ClinVar as Pathogenic (17 clinical laboratories) and as pathogenic (1 clinical laboratory) and as not provided (1 clinical laboratory) and as Pathogenic by ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel, ClinGen (expert panel).
      SpliceAI screenshot
      In silico
      SpliceAI predicts possible splice impact for this variant (max delta score = 0.86).
      Functional No data
      No calibrated functional assay or RNA evidence was identified for this variant.
      OncoKB ↗
      COSMIC screenshot
      COSMIC
      Somatic evidence
      COSMIC
      This variant has previously been reported in somatic cancers (COSMIC; COSV100524937, n = 1 times).
      Hotspots
      This variant does not lie in a statistically significant cancer hotspot.
      COSMIC ↗
      Literature · how each cited paper was used
      2papers cited
      Each card is an audit: what was searched, what was found, whether it names the variant, which criteria it fed, and why.
      PMID PMID:20020529
      Found
      Structured finding pending for this record — see source link.
      Applied to
      PVS1 supports · met
      PMID PMID:31853058
      Found
      Structured finding pending for this record — see source link.
      Applied to
      PP4 supports · met
      Sources & reference links
      7Sources
      CSpec VCEP
      ClinVar
      gnomAD v2.1
      gnomAD v4.1
      SpliceAI
      OncoKB
      COSMIC